<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02914834</url>
  </required_header>
  <id_info>
    <org_study_id>2016-0642</org_study_id>
    <secondary_id>R21NR017705-01A1</secondary_id>
    <nct_id>NCT02914834</nct_id>
  </id_info>
  <brief_title>Acupuncture for Individuals With Stable Angina</brief_title>
  <acronym>AIMS-A</acronym>
  <official_title>Feasibility Testing of a Randomized Controlled Trial of Acupuncture to Improve Symptoms for Individuals With Stable Angina (AIMS-A)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Illinois at Chicago</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Institute of Nursing Research (NINR)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Illinois at Chicago</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This RCT aims to determine if it is possible to perform acupuncture on men and women&#xD;
      diagnosed with stable angina who have symptoms, chest pain, and/or chest discomfort. The&#xD;
      investigators want to determine if acupuncture reduces the pain and other symptoms of angina,&#xD;
      chest pain, and chest discomfort. The investigators also want to examine whether this study&#xD;
      is acceptable to the participants, and by carrying out this study the investigators will be&#xD;
      able to tell how many participants they will need in a future larger study to further test&#xD;
      acupuncture to reduce the symptoms of angina in women.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The investigators are conducting a RCT aimed at gathering feasibility, and initial efficacy&#xD;
      for a randomized controlled trial (RCT) to test the effect of acupuncture on anginal&#xD;
      symptoms, chest pain, and chest discomfort in men and women. The investigators long term goal&#xD;
      is pain and symptom management resulting in improved functional status and quality of life&#xD;
      for men and women with stable angina, chest pain, and chest discomfort. This study will&#xD;
      include 69 community dwelling men and women with a medically confirmed diagnosis of stable&#xD;
      angina, chest pain which includes non-ischemic or ischemic cardiomyopathy, microvascular&#xD;
      coronary dysfunction (MCD), heart failure with preserved ejection fraction (HFpEF), heart&#xD;
      failure with reduced ejection fraction (HFrEF), or chest discomfort whose pain and associated&#xD;
      symptoms have not been completely controlled with guideline-directed medical management. The&#xD;
      investigators will use a randomized attention control design with 13 men and women assigned&#xD;
      to initial acupuncture and 13 to control. Participants in the experimental group will receive&#xD;
      a standardized acupuncture point prescription two treatments per week, for 5 weeks. The&#xD;
      attention control group will receive non-pain related video health education over 5 weeks&#xD;
      equal to the approximate 10 hours of treatment for the acupuncture group.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    Research activity halted due to the Coronavirus Disease 2019 (COVID-19) pandemic. We were&#xD;
    obliged to stop the in-person study in March 2020 due to the mandated lockdowns as a result of&#xD;
    COVID.&#xD;
  </why_stopped>
  <start_date type="Actual">May 15, 2019</start_date>
  <completion_date type="Actual">March 16, 2020</completion_date>
  <primary_completion_date type="Actual">March 16, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Feasibility of Study Protocol</measure>
    <time_frame>After 10th acupuncture treatment, at 5 weeks post-baseline (study completion)</time_frame>
    <description>Feasibility was measured by recruitment (%), retention (%), completion (%). Feasibility was defined as ≥ 80% recruitment, ≥75% retention following enrollment, and ≥ 80% completion.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Protocol Acceptability Scale for Treating Angina With Acupuncture</measure>
    <time_frame>After 10th acupuncture treatment, at 5 weeks post-baseline (study completion)</time_frame>
    <description>Protocol Acceptability Scale for Treating Angina with Acupuncture is a 9-item instrument used to measure acceptability of the study processes and protocols. Items are measured on a 0 to 2 scale, where 0 means &quot;did not like the study and did not like acupuncture&quot;, and 2 means &quot;liked the study and liked acupuncture&quot;. The protocol was deemed to have high acceptability if 80% of participants scored ≥ 80% of possible points on the acceptability scale. The investigators calculated the mean score for each of the 9 questions in each arm, divided the total score for the 9 questions by the maximum possible points for the measure (18 x number of participants in each arm), and converted the total mean scores to percentage of participants who liked the study/liked acupuncture in each arm.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Average Pain Intensity From the McGill Pain Questionnaire</measure>
    <time_frame>From before first treatment at baseline to after 10th acupuncture treatment (study completion) at 5 weeks</time_frame>
    <description>Average Pain Intensity from the McGill Pain Questionnaire is the average of pain now, least pain in the past 24 hours, and worst pain in the past 24 hours. Average Pain Intensity is scored on a 0 to 10 Likert type scale with 0 = no pain and 10 = excruciating pain. Pain intensity is the pre-specified outcome measure, while pain now and least and worst pain are values used to calculate average pain intensity and were not specified outcome measures.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Seattle Angina Questionnaire-7 (SAQ-7)</measure>
    <time_frame>From before first treatment at baseline to after 10th acupuncture treatment (study completion) at 5 weeks</time_frame>
    <description>The instrument consists of 7 items measuring functional status, symptoms, and quality of life on participants. Item responses are coded sequentially from worst to best status and range from 1 to 6, except Quality of Life (range 1-5). Scores are generated for each domain and are scaled 0 to 100, with 0 denoting the worst and 100 the best possible status.</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Inflammatory Biomarkers Blood Test</measure>
    <time_frame>From before first treatment at baseline to after 10th acupuncture treatment (study completion) at 5 weeks</time_frame>
    <description>Inflammatory biomarkers between the acupuncture and control group [interleukin (IL)- 2, IL-4, IL-6, IL-8, IL-10, IL-18; tumor necrosis factor alpha (TNF-α)]. Changes in these values from before first treatment at baseline to after 10th acupuncture treatment at 5 weeks is reported.</description>
  </other_outcome>
  <other_outcome>
    <measure>Inflammatory Biomarkers Blood Test- Mean Change C-reactive Protein (CRP)</measure>
    <time_frame>From before first treatment at baseline to after 10th acupuncture treatment (study completion) at 5 weeks.</time_frame>
    <description>Inflammatory biomarker CRP between the acupuncture and control group. Changes in these values from before first treatment at baseline to after 10th acupuncture treatment at 5 weeks is reported.</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">27</enrollment>
  <condition>Angina, Stable</condition>
  <condition>Chest Pain</condition>
  <condition>Microvascular Angina</condition>
  <condition>Heart Failure</condition>
  <arm_group>
    <arm_group_label>Device Acupuncture</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Standardized acupuncture protocol twice per week for 5 weeks for a total of 10 sessions</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Non-pain related video health education</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>The attention control group will receive non-pain related video health education over 5 weeks equal to the approximate 10 hours of treatment for the acupuncture group.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Acupuncture</intervention_name>
    <description>Standardized acupuncture treatment administered for 30 minutes each session</description>
    <arm_group_label>Device Acupuncture</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Non-pain related video health education</intervention_name>
    <description>Attention control group will watch health education videos the equivalent of 10 hours from randomization up to study completion.</description>
    <arm_group_label>Non-pain related video health education</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion criteria:&#xD;
&#xD;
          -  provision of a verified diagnosis from a care provider&#xD;
&#xD;
          -  male or female sex&#xD;
&#xD;
          -  at least 21 years of age&#xD;
&#xD;
          -  intermittent angina symptoms (pain, pressure, or discomfort in the chest or other&#xD;
             areas of the upper body)&#xD;
&#xD;
          -  medical confirmation of a diagnosis of stable angina for at least 6 months&#xD;
&#xD;
        medical confirmation of a diagnosis of chest pain including non-ischemic or ischemic&#xD;
        cardiomyopathy&#xD;
&#xD;
        medical confirmation of a diagnosis of microvascular coronary dysfunction (MCD)&#xD;
&#xD;
        medical confirmation of a diagnosis of heart failure with preserved ejection fraction&#xD;
        (HFpEF), heart failure with reduced ejection fraction (HFrEF) medical confirmation of chest&#xD;
        discomfort.&#xD;
&#xD;
        Exclusion criteria:&#xD;
&#xD;
          -  pregnancy&#xD;
&#xD;
          -  chronic obstructive pulmonary disease (COPD) causing pain or associated symptoms&#xD;
&#xD;
          -  autoimmune dysfunction&#xD;
&#xD;
          -  use of steroid medications&#xD;
&#xD;
          -  concomitant physical therapy&#xD;
&#xD;
          -  biofeedback&#xD;
&#xD;
          -  massage&#xD;
&#xD;
          -  additional acupuncture&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Holli A DeVon, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Illinois at Chicago</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Illinois at Chicago College of Nursing</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60612</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>August 13, 2016</study_first_submitted>
  <study_first_submitted_qc>September 23, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 26, 2016</study_first_posted>
  <results_first_submitted>March 16, 2021</results_first_submitted>
  <results_first_submitted_qc>October 4, 2021</results_first_submitted_qc>
  <results_first_posted type="Actual">October 7, 2021</results_first_posted>
  <last_update_submitted>October 4, 2021</last_update_submitted>
  <last_update_submitted_qc>October 4, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 7, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Illinois at Chicago</investigator_affiliation>
    <investigator_full_name>Judith Schlaeger</investigator_full_name>
    <investigator_title>Assistant Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Angina Pectoris</mesh_term>
    <mesh_term>Angina, Stable</mesh_term>
    <mesh_term>Microvascular Angina</mesh_term>
    <mesh_term>Chest Pain</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>July 28, 2019</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/34/NCT02914834/Prot_SAP_000.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Device Acupuncture</title>
          <description>Standardized acupuncture protocol twice per week for 5 weeks for a total of 10 sessions&#xD;
Acupuncture: Standardized acupuncture treatment administered for 30 minutes each session</description>
        </group>
        <group group_id="P2">
          <title>Non-pain Related Video Health Education</title>
          <description>The attention control group will receive non-pain related video health education over 5 weeks equal to the approximate 10 hours of treatment for the acupuncture group.&#xD;
Non-pain related video health education: Attention control group will watch health education videos the equivalent of 10 hours from randomization up to study completion.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="12"/>
                <participants group_id="P2" count="15"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="11"/>
                <participants group_id="P2" count="13"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="2"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Study halted due to COVID</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>1 subject withdrew</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>27 subjects recruited and enrolled, 24 subjects completed the trial.</population>
      <group_list>
        <group group_id="B1">
          <title>Device Acupuncture</title>
          <description>Standardized acupuncture protocol twice per week for 5 weeks for a total of 10 sessions&#xD;
Acupuncture: Standardized acupuncture treatment administered for 30 minutes each session</description>
        </group>
        <group group_id="B2">
          <title>Non-pain Related Video Health Education</title>
          <description>The attention control group will receive non-pain related video health education over 5 weeks equal to the approximate 10 hours of treatment for the acupuncture group.&#xD;
Non-pain related video health education: Attention control group will watch health education videos the equivalent of 10 hours from randomization up to study completion.</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="12"/>
            <count group_id="B2" value="15"/>
            <count group_id="B3" value="27"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="8"/>
                    <measurement group_id="B2" value="11"/>
                    <measurement group_id="B3" value="19"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="4"/>
                    <measurement group_id="B2" value="4"/>
                    <measurement group_id="B3" value="8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="8"/>
                    <measurement group_id="B2" value="9"/>
                    <measurement group_id="B3" value="17"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="4"/>
                    <measurement group_id="B2" value="6"/>
                    <measurement group_id="B3" value="10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Ethnicity (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="4"/>
                    <measurement group_id="B2" value="5"/>
                    <measurement group_id="B3" value="9"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Not Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="8"/>
                    <measurement group_id="B2" value="10"/>
                    <measurement group_id="B3" value="18"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>American Indian or Alaska Native</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Asian</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Native Hawaiian or Other Pacific Islander</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Black or African American</title>
                  <measurement_list>
                    <measurement group_id="B1" value="6"/>
                    <measurement group_id="B2" value="8"/>
                    <measurement group_id="B3" value="14"/>
                  </measurement_list>
                </category>
                <category>
                  <title>White</title>
                  <measurement_list>
                    <measurement group_id="B1" value="4"/>
                    <measurement group_id="B2" value="3"/>
                    <measurement group_id="B3" value="7"/>
                  </measurement_list>
                </category>
                <category>
                  <title>More than one race</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="2"/>
                    <measurement group_id="B3" value="3"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="2"/>
                    <measurement group_id="B3" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="12"/>
                    <measurement group_id="B2" value="15"/>
                    <measurement group_id="B3" value="27"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Feasibility of Study Protocol</title>
        <description>Feasibility was measured by recruitment (%), retention (%), completion (%). Feasibility was defined as ≥ 80% recruitment, ≥75% retention following enrollment, and ≥ 80% completion.</description>
        <time_frame>After 10th acupuncture treatment, at 5 weeks post-baseline (study completion)</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Device Acupuncture</title>
            <description>Standardized acupuncture protocol twice per week for 5 weeks for a total of 10 sessions&#xD;
Acupuncture: Standardized acupuncture treatment administered for 30 minutes each session</description>
          </group>
          <group group_id="O2">
            <title>Non-pain Related Video Health Education</title>
            <description>The attention control group will receive non-pain related video health education over 5 weeks equal to the approximate 10 hours of treatment for the acupuncture group.&#xD;
Non-pain related video health education: Attention control group will watch health education videos the equivalent of 10 hours from randomization up to study completion.</description>
          </group>
        </group_list>
        <measure>
          <title>Feasibility of Study Protocol</title>
          <description>Feasibility was measured by recruitment (%), retention (%), completion (%). Feasibility was defined as ≥ 80% recruitment, ≥75% retention following enrollment, and ≥ 80% completion.</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="12"/>
                <count group_id="O2" value="15"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Participants recruited</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="12"/>
                    <measurement group_id="O2" value="15"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Participants retained</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="12"/>
                    <measurement group_id="O2" value="15"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Participants completed</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="11"/>
                    <measurement group_id="O2" value="13"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Protocol Acceptability Scale for Treating Angina With Acupuncture</title>
        <description>Protocol Acceptability Scale for Treating Angina with Acupuncture is a 9-item instrument used to measure acceptability of the study processes and protocols. Items are measured on a 0 to 2 scale, where 0 means &quot;did not like the study and did not like acupuncture&quot;, and 2 means &quot;liked the study and liked acupuncture&quot;. The protocol was deemed to have high acceptability if 80% of participants scored ≥ 80% of possible points on the acceptability scale. The investigators calculated the mean score for each of the 9 questions in each arm, divided the total score for the 9 questions by the maximum possible points for the measure (18 x number of participants in each arm), and converted the total mean scores to percentage of participants who liked the study/liked acupuncture in each arm.</description>
        <time_frame>After 10th acupuncture treatment, at 5 weeks post-baseline (study completion)</time_frame>
        <population>Those completing the study protocol at 5 weeks</population>
        <group_list>
          <group group_id="O1">
            <title>Device Acupuncture</title>
            <description>Standardized acupuncture protocol twice per week for 5 weeks for a total of 10 sessions&#xD;
Acupuncture: Standardized acupuncture treatment administered for 30 minutes each session</description>
          </group>
          <group group_id="O2">
            <title>Non-pain Related Video Health Education</title>
            <description>The attention control group will receive non-pain related video health education over 5 weeks equal to the approximate 10 hours of treatment for the acupuncture group.&#xD;
Non-pain related video health education: Attention control group will watch health education videos the equivalent of 10 hours from randomization up to study completion.</description>
          </group>
        </group_list>
        <measure>
          <title>Protocol Acceptability Scale for Treating Angina With Acupuncture</title>
          <description>Protocol Acceptability Scale for Treating Angina with Acupuncture is a 9-item instrument used to measure acceptability of the study processes and protocols. Items are measured on a 0 to 2 scale, where 0 means &quot;did not like the study and did not like acupuncture&quot;, and 2 means &quot;liked the study and liked acupuncture&quot;. The protocol was deemed to have high acceptability if 80% of participants scored ≥ 80% of possible points on the acceptability scale. The investigators calculated the mean score for each of the 9 questions in each arm, divided the total score for the 9 questions by the maximum possible points for the measure (18 x number of participants in each arm), and converted the total mean scores to percentage of participants who liked the study/liked acupuncture in each arm.</description>
          <population>Those completing the study protocol at 5 weeks</population>
          <units>percentage of subjects who liked study</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="11"/>
                <count group_id="O2" value="13"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="87.9"/>
                    <measurement group_id="O2" value="51.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Average Pain Intensity From the McGill Pain Questionnaire</title>
        <description>Average Pain Intensity from the McGill Pain Questionnaire is the average of pain now, least pain in the past 24 hours, and worst pain in the past 24 hours. Average Pain Intensity is scored on a 0 to 10 Likert type scale with 0 = no pain and 10 = excruciating pain. Pain intensity is the pre-specified outcome measure, while pain now and least and worst pain are values used to calculate average pain intensity and were not specified outcome measures.</description>
        <time_frame>From before first treatment at baseline to after 10th acupuncture treatment (study completion) at 5 weeks</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Device Acupuncture</title>
            <description>Standardized acupuncture protocol twice per week for 5 weeks for a total of 10 sessions&#xD;
Acupuncture: Standardized acupuncture treatment administered for 30 minutes each session</description>
          </group>
          <group group_id="O2">
            <title>Non-pain Related Video Health Education</title>
            <description>The attention control group will receive non-pain related video health education over 5 weeks equal to the approximate 10 hours of treatment for the acupuncture group.&#xD;
Non-pain related video health education: Attention control group will watch health education videos the equivalent of 10 hours from randomization up to study completion.</description>
          </group>
        </group_list>
        <measure>
          <title>Average Pain Intensity From the McGill Pain Questionnaire</title>
          <description>Average Pain Intensity from the McGill Pain Questionnaire is the average of pain now, least pain in the past 24 hours, and worst pain in the past 24 hours. Average Pain Intensity is scored on a 0 to 10 Likert type scale with 0 = no pain and 10 = excruciating pain. Pain intensity is the pre-specified outcome measure, while pain now and least and worst pain are values used to calculate average pain intensity and were not specified outcome measures.</description>
          <units>score on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="11"/>
                <count group_id="O2" value="13"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline Average pain intensity</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.81" spread="1.99"/>
                    <measurement group_id="O2" value="3.42" spread="2.56"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Completion Average pain intensity</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.21" spread="1.13"/>
                    <measurement group_id="O2" value="2.97" spread="1.96"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Seattle Angina Questionnaire-7 (SAQ-7)</title>
        <description>The instrument consists of 7 items measuring functional status, symptoms, and quality of life on participants. Item responses are coded sequentially from worst to best status and range from 1 to 6, except Quality of Life (range 1-5). Scores are generated for each domain and are scaled 0 to 100, with 0 denoting the worst and 100 the best possible status.</description>
        <time_frame>From before first treatment at baseline to after 10th acupuncture treatment (study completion) at 5 weeks</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Device Acupuncture</title>
            <description>Standardized acupuncture protocol twice per week for 5 weeks for a total of 10 sessions&#xD;
Acupuncture: Standardized acupuncture treatment administered for 30 minutes each session</description>
          </group>
          <group group_id="O2">
            <title>Non-pain Related Video Health Education</title>
            <description>The attention control group will receive non-pain related video health education over 5 weeks equal to the approximate 10 hours of treatment for the acupuncture group.&#xD;
Non-pain related video health education: Attention control group will watch health education videos the equivalent of 10 hours from randomization up to study completion.</description>
          </group>
        </group_list>
        <measure>
          <title>Seattle Angina Questionnaire-7 (SAQ-7)</title>
          <description>The instrument consists of 7 items measuring functional status, symptoms, and quality of life on participants. Item responses are coded sequentially from worst to best status and range from 1 to 6, except Quality of Life (range 1-5). Scores are generated for each domain and are scaled 0 to 100, with 0 denoting the worst and 100 the best possible status.</description>
          <units>score on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="11"/>
                <count group_id="O2" value="13"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline Functional status</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="16.67" spread="15.18"/>
                    <measurement group_id="O2" value="29.78" spread="26.77"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Completion Functional status</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="46.67" spread="27.49"/>
                    <measurement group_id="O2" value="16.92" spread="19.36"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Baseline symptoms</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="55.00" spread="20.23"/>
                    <measurement group_id="O2" value="62.67" spread="13.35"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Completion Symptoms</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="72.73" spread="15.55"/>
                    <measurement group_id="O2" value="56.15" spread="8.70"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Baseline Quality of Life</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="20.83" spread="26.82"/>
                    <measurement group_id="O2" value="16.67" spread="13.91"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Completion Quality of life</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="54.55" spread="23.90"/>
                    <measurement group_id="O2" value="11.54" spread="12.97"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Baseline Total score</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="29.29" spread="13.01"/>
                    <measurement group_id="O2" value="36.57" spread="16.14"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Completion Total score</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="56.44" spread="19.74"/>
                    <measurement group_id="O2" value="27.51" spread="9.21"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Inflammatory Biomarkers Blood Test</title>
        <description>Inflammatory biomarkers between the acupuncture and control group [interleukin (IL)- 2, IL-4, IL-6, IL-8, IL-10, IL-18; tumor necrosis factor alpha (TNF-α)]. Changes in these values from before first treatment at baseline to after 10th acupuncture treatment at 5 weeks is reported.</description>
        <time_frame>From before first treatment at baseline to after 10th acupuncture treatment (study completion) at 5 weeks</time_frame>
        <population>Overall number of participants analyzed differ based on difficulty drawing blood on subjects.</population>
        <group_list>
          <group group_id="O1">
            <title>Device Acupuncture</title>
            <description>Standardized acupuncture protocol twice per week for 5 weeks for a total of 10 sessions&#xD;
Acupuncture: Standardized acupuncture treatment administered for 30 minutes each session</description>
          </group>
          <group group_id="O2">
            <title>Non-pain Related Video Health Education</title>
            <description>The attention control group will receive non-pain related video health education over 5 weeks equal to the approximate 10 hours of treatment for the acupuncture group.&#xD;
Non-pain related video health education: Attention control group will watch health education videos the equivalent of 10 hours from randomization up to study completion.</description>
          </group>
        </group_list>
        <measure>
          <title>Inflammatory Biomarkers Blood Test</title>
          <description>Inflammatory biomarkers between the acupuncture and control group [interleukin (IL)- 2, IL-4, IL-6, IL-8, IL-10, IL-18; tumor necrosis factor alpha (TNF-α)]. Changes in these values from before first treatment at baseline to after 10th acupuncture treatment at 5 weeks is reported.</description>
          <population>Overall number of participants analyzed differ based on difficulty drawing blood on subjects.</population>
          <units>pg/ml</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="6"/>
                <count group_id="O2" value="11"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Mean change IL-2</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="6"/>
                    <count group_id="O2" value="11"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.394" spread="22.523"/>
                    <measurement group_id="O2" value="11.595" spread="17.414"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Mean Change IL-4</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="6"/>
                    <count group_id="O2" value="11"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-1.444" spread="2.724"/>
                    <measurement group_id="O2" value="-.818" spread="2.306"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Mean Change IL-6</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="6"/>
                    <count group_id="O2" value="10"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-.096" spread=".863"/>
                    <measurement group_id="O2" value="-.212" spread="1.224"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Mean Change IL-8</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="6"/>
                    <count group_id="O2" value="11"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.065" spread="7.671"/>
                    <measurement group_id="O2" value="1.255" spread="5.373"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Mean Change IL-10</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="6"/>
                    <count group_id="O2" value="11"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.317" spread="14.373"/>
                    <measurement group_id="O2" value="7.386" spread="38.165"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Mean Change IL-18</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="6"/>
                    <count group_id="O2" value="11"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="55.695" spread="65.646"/>
                    <measurement group_id="O2" value="16.540" spread="68.665"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Mean change TNF-alpha</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="6"/>
                    <count group_id="O2" value="10"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6.312" spread="25.370"/>
                    <measurement group_id="O2" value="8.763" spread="20.667"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Inflammatory Biomarkers Blood Test- Mean Change C-reactive Protein (CRP)</title>
        <description>Inflammatory biomarker CRP between the acupuncture and control group. Changes in these values from before first treatment at baseline to after 10th acupuncture treatment at 5 weeks is reported.</description>
        <time_frame>From before first treatment at baseline to after 10th acupuncture treatment (study completion) at 5 weeks.</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Device Acupuncture</title>
            <description>Standardized acupuncture protocol twice per week for 5 weeks for a total of 10 sessions&#xD;
Acupuncture: Standardized acupuncture treatment administered for 30 minutes each session</description>
          </group>
          <group group_id="O2">
            <title>Non-pain Related Video Health Education</title>
            <description>The attention control group will receive non-pain related video health education over 5 weeks equal to the approximate 10 hours of treatment for the acupuncture group.&#xD;
Non-pain related video health education: Attention control group will watch health education videos the equivalent of 10 hours from randomization up to study completion.</description>
          </group>
        </group_list>
        <measure>
          <title>Inflammatory Biomarkers Blood Test- Mean Change C-reactive Protein (CRP)</title>
          <description>Inflammatory biomarker CRP between the acupuncture and control group. Changes in these values from before first treatment at baseline to after 10th acupuncture treatment at 5 weeks is reported.</description>
          <units>ng/ml</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="6"/>
                <count group_id="O2" value="11"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-302.903" spread="1049.445"/>
                    <measurement group_id="O2" value="-457.205" spread="1416.052"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Adverse Event data were collected over the duration of the 5-week study protocol</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Device Acupuncture</title>
          <description>Standardized acupuncture protocol twice per week for 5 weeks for a total of 10 sessions&#xD;
Acupuncture: Standardized acupuncture treatment administered for 30 minutes each session</description>
        </group>
        <group group_id="E2">
          <title>Non-pain Related Video Health Education</title>
          <description>The attention control group will receive non-pain related video health education over 5 weeks equal to the approximate 10 hours of treatment for the acupuncture group.&#xD;
Non-pain related video health education: Attention control group will watch health education videos the equivalent of 10 hours from randomization up to study completion.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="15"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="15"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="15"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Judith Schlaeger, PhD</name_or_title>
      <organization>University of Illinois Chicago</organization>
      <phone>3124134669</phone>
      <email>jschlaeg@uic.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

